INTERNATIONAL MULTI-INSTITUTIONAL RESEARCH BY TARPSWG
Check out the Studies that have been done and are currently recruiting for Collaborative Research:
FOR MORE INFORMATION ON ANY OF THESE STUDIES PLEASE CONTACT: tarpswg@gmail.com
Studies open to accrual
TARPSWG RETROSPECTIVE STUDIES
No Open Studies Currently
RESAR PROSPECTIVE STUDIES
No Open Studies Currently
Closed studies – in progress
TARPSWG RETROSPECTIVE STUDIES
TARPSWG – 2101
Retroperitoneal Lipoma: How rare are they? By the TARPSWG group
- PI: William Tseng MD (University of Southern California, Los Angeles, US); Alessandro Gronchi (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy); Chandrajit Raut, MD (Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, US)
- Co-I: Andre Oliveira, MD ; Judith Jebastin Thangaiah, MD (Mayo Clinic Rochester, US)
- Status: Closed
- Eligibility: Primary Retroperitoneal (RP) Lipomatous Tumors – including lipoma, WD liposarcoma, and angiomyolipoma. Our focus will ultimately be on RP lipomas. Minimum of 1 case required to enter the study
TARPSWG – 2102
The natural history of primary, extra-visceral, perivascular epitheloid cel tumours (PEComa) of the Retroperitoneum: The combined experience of the TARPSWG
- PI: David Gyorki MD (Peter MacCallum Cancer Center, Melbourne, Australia)
- Co-Is: Sameer Apte MD, Hayden Snow MD, Catherine Micthell MD (Peter MacCallum Cancer Center, Melbourne, Australia)
- Status: Closed
- Eligibility: Patients 18 years or older diagnosed with a primary, extra-visceral, retroperitoneal or abdominopelvic PEComa, or a tumour belonging to the family of PEComas over the past 10 years. Minimum of 1 case required to enter the study
TARPSWG – 2103
Evaluating international patterns of textbook outcomes in surgical resection of retroperitoneal sarcoma: A TARPSWG Study.
- PI: Joal Beane MD (The Ohio State James Comprehensive Cancer Center)
- Co-Is: Raphael Pollock MD, Valerie Grignol MD, Farhan Ilyas MD (The Ohio State James Comprehensive Cancer Center)
- Status: Closed
- Eligibility: All patients 18 years or older undergoing resection of retroperitoneal sarcoma from January 2010 to December 2020 with the intention of curative treatment. Minimum of 10 cases required to enter the study.
TARPSWG – 2002
Spermatic Cord Sarcomas – A Retrospective Analysis of Diagnosis, Clinical Features, Treatment Patterns and Outcomes (SARCORD) – A study by TARPSWG
- PI: Sinziana Dumitra MD (McGill University, Montreal, Canada)
- Co-I: Alessandro Gronchi (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)
- Status: Closed
- Eligibility: Any center can contribute to this study. All patients who have a primary soft tissue sarcoma originating from the spermatic cord between Jan 2005 and Dec 2018. Minimum of 1 case required to enter the study
TARPSWG-2009
The Natural History of Well-differentiated Liposarcoma in the Retroperitoneum: A TARPSWG Study
- PIs: Mark Fairweather, MD (Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, US); Chandrajit Raut, MD (Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, US)
- Status: Closed, Currently Analyzing Data
TARPSWG-2001
The Evaluation and Outcome of Mesenteric and Intra-Abdominal Desmoids: A study by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
- PIs: Carolyn Nessim, MD, MSc (The Ottawa Hospital, Ottawa, Canada) ; Alessandro Gronchi, MD (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)
- Co-I: Kerianne Boulva, MD (The Ottawa Hospital, Ottawa, Canada)
- Status: Closed, Data Clean Up
TARPSWG-1803
Retroperitoneal Myxoid LPS: Always a Metastasis? A study by the Trans-Atlantic Australasian RPS Working Group (TARPSWG).
- PIs: Carolyn Nessim, MD, MSc (The Ottawa Hospital, Ottawa, Canada) ; Chandrajit, MD (Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, US)
- Co-I: Bibianna Purgina, MD (The Ottawa Hospital, Ottawa, Canada)
- Status: Closed, Awaiting Material for MDM2 testing
TARPSWG-1805
STREXIT – “off trial” management and outcomes of primary non-metastatic RPS at centres that participated in the STRASS trial
- PIs: Carol Swallow, MD, PhD (Mount Sinai Hospital, Princess Margaret Hospital, University of Toronto, Toronto, Canada) ; Alessandro Gronchi, MD (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy) ; Chandrajit Raut, MD (Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, US) ;Sylvie Bonvalot, MD (Institut Curie, PSL University, Paris, France)
- Status: Closed, Manuscript in Progress
TARPSWG-1807
Pelvic Sarcomas – Retrospective Analysis of Clinical and Surgical Features and Outcomes (PELVISARC): A study by the Trans-Atlantic Australasian RPS Working Group (TARPSWG).
- PIs: Marco Fiore, MD (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy) ; Sinziana Dumitra, MD (MgGill University Health Center, Montreal, Canada)
- Co-I: Alessandro Gronchi, MD (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)
- Status: Closed, Currently Analyzing Data
RESAR PROSPECTIVE STUDIES
TARPSWG – R1906
Benchmarks in RPS Surgery – A study by TARPSWG
- PIs: Alessandro Gronchi MD, Marco Fiore MD (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy); Fabio Tirotta MD (University Hospital Birmingham NHS Foundation Trust, Birmingham, UK)
- Status: Closed
- Eligibility: Patients who underwent surgery for primary RPS at RESAR participating centers between January 2017 and June 2021. Minimum of 10 cases required to enter the study
TARPSWG-R2007
Response Evaluation after Neo-adjuvant Chemotherapy for Retroperitoneal Sarcoma
- PIs: Winan vanHoudt MD (The Netherlands Cancer Institute, Amsterdam, Netherlands); Alessandro Gronchi, MD (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)
- Co-I: Sophie Rejjers MD (The Netherlands Cancer Institute, Amsterdam, Netherlands)
- Status: Closed, Receiving Data from Centers
TARPSWG-R1901
Evaluating a Surgical Complexity Score to predict complications Post-Resection of a Retroperitoneal Sarcoma: A study by the Trans-Atlantic Australasian RPS Working Group (TARPSWG).
- PI: Mark Fairweather, MD (Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, US)
- Co-I: Chandrajit Raut, MD (Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, US)
- Status: Closed, Currently Analyzing Data
TARPSWG–R2005
Variations in patterns of care for retroperitoneal sarcoma: a study of the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group
- PI: Hayden Snow, MD (Peter MacCallum Cancer Center, Melbourne, Australia
- Co-I: David Gyorki, MD (Peter MacCallum Cancer Center, Melbourne, Australia
- Status: Closed, Receiving Data from Centers
TARPSWG–R2006
Anticipated organs resection and pathologic infiltration – RESAntiPath
- PIs: Marco Fiore, MD; Alessandro Gronchi (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)
- Co-I: Dirk Strauss, MD (Royal Marsden Hospital, London, UK)
- Status: Closed, Receiving Data from Centers
TARPSWG-R1905 (RESAR Project)
Accuracy and Concordance of Biopsy Diagnosis in Retroperitoneal Sarcoma (BISARC): An International Multi-Institutional Prospective Study by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
- PIs: Sinziana Dumitra, MD (MgGill University Health Center, Montreal, Canada) ; Alessandro Gronchi, MD (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)
- Co-I: Max Almond, MD (University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK)
- Status: Closed, Receiving Data from Centers
Published papers
TARPSWG-2003
The Natural History of Ganglioneuroma: A Study by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
- PI: Jason Sicklick, MD (Moores Cancer Center, University of California San Diego Health System, San Diego, US)
- Co-Is: Sangkyu Noh, MS (Moores Cancer Center, University of California San Diego Health System, San Diego, US) ; Carolyn Nessim, MD, MSc, (The Ottawa Hospital, Ottawa, Canada)
- Publication: https://pubmed.ncbi.nlm.nih.gov/35866666/
TARPSWG – 1904
An Analysis on Differentiation Changes and Outcomes at the Time of First Recurrence of Retroperitoneal Liposarcoma by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
- PIs: Carolyn Nessim, MD, MSc (The Ottawa Hospital, Ottawa, Canada); Sanjay P Bagaria, MD, (Mayo Clinic, Jacksonville, US)
- Co-Is: Chandrajit Raut, MD (Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, US) ; Alessandro Gronchi, MD (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)
TARPSWG – CONSENSUS
Development of an Updated International Consensus on the Management of Primary Retroperitoneal Sarcoma (RPS) by TARPSWG
TARPSWG-1804
Primary Mesenteric Sarcomas – A Collaborative experience by the Trans-Atlantic Australasian RPS Working Group (TARPSWG).
- PIs: Sam Ford, MD, PhD ; Hannah Tattersall, MD (University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK)
- Co-I: Alessandro Gronchi, MD (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)
- Publication : https://pubmed.ncbi.nlm.nih.gov/33368277/
TARPSWG-1802
Postoperative pancreatic fistula following distal pancreatectomy for primary retroperitoneal sarcoma: an analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
- PIs: Sanjay Bagaria, MD (Mayo Clinic, Jacksonville, US) ; Alessandro Gronchi, MD (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)
TARPSWG-1801
Defining the Role of Neo-Adjuvant Systemic Therapy in High Risk Retroperitoneal Sarcoma: A Multi-Institutional TARPSWG Study
- PIs: William Tseng MD (University of Southern California, Keck School of Medicine, LA, US ) ; Alessandro Gronchi, MD (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)
TARPSWG-1902
Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Trans-Atlantic Australasian RPS Working Group (TARPSWG).
- PIs: Carolyn Nessim, MD, MSc (The Ottawa Hospital, Ottawa, Canada); Guy Lahat, MD, (Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel)
- Co-Is: Chandrajit Raut, MD (Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, US) ; Alessandro Gronchi, MD (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)
TARPSWG-2007
Virtual Biobanking for Retroperitoneal Sarcoma: A Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) Initiative
PIs: Rebecca Gladdy Md, PhD (University of Toronto); Alessandro Gronchi, MD (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)
Publication: https://link.springer.com/article/10.1245%2Fs10434-020-08775-1
TARPSWG-1903
Patterns of Recurrence and Survival Probability following Second Relapse of Retroperitoneal Sarcoma: A Study from TARPSWG
- PIs: Winan vanHoudt, MD (The Netherlands Cancer Institute, Amsterdam Netherlands) ; Rebecca Gladdy, MD, PhD (Mount Sinai Hospital, Princess Margaret Hospital, University of Toronto, Toronto, Canada)
- Co-I: Marco Fiore, MD (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan Italy)
TARPSWG-1700
Intercontinental Collaborative Experience with abdominal, retroperitoneal and pelvic schwannomas.
- PIs: Sam Ford MD, PhD (University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK) ; Alessandro Gronchi, MD (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)
TARPSWG-1701
Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG
- PIs: Chandrajit Raut, MD (Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, US) ; Alessandro Gronchi, MD (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)
TARPSWG-1702
Pancreaticoduodenectomy in the surgical management of primary retroperitoneal sarcoma.
- PIs: William Tseng MD (University of Southern California, Keck School of Medicine, LA, US ) ; Alessandro Gronchi, MD (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)
TARPSWG-1806
Identifying the Minimum Volume Threshold for Retroperitoneal Soft Tissue Sarcoma Resection: Merging National Data with Consensus Expert Opinion.
- PIs: Waddah Al-Rafaie, MD (MedStar Georgetown University Hospital, Washington, DC)
- Co-Is: Anthony M. Villano, MD, Alexander Zeymo, MS, Suzanne O’Neill, PhD, (MedStar Georgetown University Hospital, Washington, DC)
TARPSWG
Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS) A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group
- PIs: Chandrajit Raut, MD (Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, US) ; Alessandro Gronchi, MD (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)
- Co-Is: Carol Swallow (University of Toronto); Dirk Strauss (Royal Marsden); Sylvie Bonavalot (Institut Curie) et al.
- Publication:https://tarpswg.files.wordpress.com/2017/04/08_variability-in-pattern-of-recurrence-tarpswg.pdf
TARPSWG
Post-relapse Outcomes After Primary Extended Resection of Retroperitoneal Sarcoma: A Report From the Trans-Atlantic RPS Working Group
- PIs: Carol Swallow (University of Toronto); Andrea MacNeill (Vancouver)
- Co-Is: Chandrajit Raut, MD (Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, US) ; Alessandro Gronchi, MD (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy); Dirk Strauss (Royal Marsden); Sylvie Bonavalot (Institut Curie) et al.
TARPSWG
Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma A Report From the Transatlantic RPS Working Group
- PIs: Dirk Strauss (Royal Marsden); Andrea MacNeill (Vancouver)
- Co-Is: Chandrajit Raut, MD (Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, US) ; Alessandro Gronchi, MD (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy); Sylvie Bonavalot (Institut Curie); Carol Swallow (Unvisersity of Toronto) et al.
- Publication:https://tarpswg.files.wordpress.com/2017/05/morbidity-tarpswg.pdf
TARPSWG
Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group
- PIs: Rick Hass (The Netherlands Cancer Institute); Alessandro Gronchi, MD (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)
- Co-Is: Chandrajit Raut, MD (Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, US) ; Sylvie Bonavalot (Institut Curie); Carol Swallow (Unvisersity of Toronto); Piotr Rutkowski (Maria Sklodowska‐Curie Institute–Oncology Center) et al.
TARPSWG
External validation of a multi-institutional retroperitoneal sarcoma nomogram
- PIs: Chandrajit Raut, MD (Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, US); Alessandro Gronchi, MD (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)
- Co-Is: Sylvie Bonavalot (Institut Curie); Carol Swallow (Unvisersity of Toronto); Piotr Rutkowski (Maria Sklodowska‐Curie Institute–Oncology Center); Peter Hohenberger (Mannheim University); Dirk Strauss (Royal Marsden) et al.
TARPSWG – CONSENSUS
Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach From the Trans-Atlantic RPS Working Group
TARPSWG – CONSENSUS
Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group
TARPSWG – CONSENSUS
Management of metastatic retroperitoneal sarcoma: a consensus approach from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG)